SCHEMBL25501753

SCHEMBL25501753

O=S(=O)(Nc1cccc(C(F)(F)F)c1)N1CCCC(C(c2ccc(F)cc2)c2ccc(F)cc2)C1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.46
HTT P42858 2/20 0.46
XBP1 P17861 1/20 0.46
TACR1 P25103 2/20 0.44
KMT2A Q03164 3/20 0.43
MEN1 O00255 1/20 0.43
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
FKBP1A P62942 1/20 0.41
GLA P06280 1/20 0.41
UBE2M P61081 2/20 0.41
DCUN1D1 Q96GG9 2/20 0.41
TSHR P16473 1/20 0.41
KDM4E B2RXH2 1/20 0.40
TP53 P04637 3/20 0.40
RXFP1 Q9HBX9 1/20 0.40
GRIN2B Q13224 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23832810 0.88 KMT2A (0.50) TACR1KMT2AMEN1FKBP1AGLA
SCHEMBL25501762 0.87 KMT2A (0.52) MAPTHTTKMT2AMEN1FKBP1A
SCHEMBL25502057 0.86 KMT2A (0.43) MAPTHTTXBP1KMT2AMEN1
SCHEMBL23832802 0.85 KMT2A (0.51) MAPTHTTTACR1KMT2AMEN1
SCHEMBL23832804 0.85 KMT2A (0.51) MAPTHTTTACR1KMT2AMEN1
SCHEMBL25502058 0.85 KMT2A (0.51) MAPTHTTTACR1KMT2AMEN1
SCHEMBL23848269 0.84 KMT2A (0.58) MAPTHTTKMT2AMEN1CYP3A4
SCHEMBL23848604 0.82 TACR1 (0.43) MAPTHTTXBP1TACR1KMT2A
SCHEMBL23832777 0.81 POLB (0.47) MAPTHTTKMT2AMEN1FKBP1A
SCHEMBL25168240 0.81 POLB (0.47) MAPTHTTKMT2AMEN1FKBP1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230146127-A1 3-DIARYLMETHYLENES AND USES THEREOF ATUX ISKAY LLC 2023-05-11 US disclosed
US-20230146127-A1 3-DIARYLMETHYLENES AND USES THEREOF ATUX ISKAY LLC 2023-05-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230146127-A1 3-DIARYLMETHYLENES AND USES THEREOF MYC, MYCBP, FOXO1 MAPT 2576/4885HTT 2068/4885XBP1 436/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.